Abstract
An ‘animal model’ of depression, based on bulbectomy, followed by chronic treatment with amitryptiline was used in rats. In the synaptosomal membranes of the cerebral cortex plus hippocampus, the number of binding sites for 3H-imipramine increased significantly when bulbectomy was associated with the antidepressant. In the bulbectomized rats the tendency was toward a decrease in binding. The treatment with 0.2% Triton X-100 of the membranes revealed a large increase in postsynaptic sites in the bulbectomized treated rats. The behavioral parameters analyzed by the swimming with a water wheel and the open field test revealed a series of differences in the various groups of rats, with respect to handling, bulbectomy and antidepressant treatment. Handling resulted in an increase in swimming time in controls, while bulbectomy reduced this parameter. In both the swimming and open fields tests, chronic bulbectomy reduces the motility of the rat. In control rats chronic amitryptiline increases locomotion and exploratory activity, a behavioral effect that is even more prominent in bulbectomized treated rats.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
